The aim of this study was to elucidate the absorption mechanism in Caco-2 and rat intestine models in order to improve the accuracy of prediction of oral absorption of ester prodrugs. Pivampicillin and cefcapene pivoxil hydrochloride (CFPN-PI), ester-type oral antibiotics, were chosen as model ester prodrugs. The level of esterase activity in Caco-2 cells was lower than that measured in the rat jejunum when p-nitrophenyl acetate was used as a substrate. Almost complete ester hydrolysis occurred before the ester prodrugs reached the basolateral side of the monolayer, and the disappearance of prodrugs was thought to be due to metabolism or transport after addition to the apical side of the monolayer. When pivampicillin and CFPN-PI were used, the amounts of ampicillin and cefcapene (CFPN) produced by hydrolysis of prodrugs were increased because intracellular degradation of prodrugs resulted in intracellular accumulation. On the other hand, when ampicillin or CFPN was used, only a small amount of the drug reached the basolateral side of the monolayers and no intracellular accumulation was observed. The permeability of CFPN-PI, the solubility of which is dependent on the acidity of gastric juice, across a Caco-2 monolayer or rat intestine, was also investigated by using an in vitro system that mimics the physiological state of the human gastrointestinal tract. The oral absorption of CFPN-PI in humans is predicted to be good either in the Caco-2 model or in the rat intestine model. It is concluded that our system may be a valuable tool for evaluation of oral absorption of ester prodrugs metabolized during permeation through the intestinal epithelium. Broader evaluation of such a system is warranted.
机构:
Wyeth Ayerst Res, Chem & Screening Sci, Chem Technol, Pearl River, NY 10965 USAWyeth Ayerst Res, Chem & Screening Sci, Chem Technol, Pearl River, NY 10965 USA
Press, Barry
Di Grandi, Deanna
论文数: 0引用数: 0
h-index: 0
机构:
Wyeth Ayerst Res, Chem & Screening Sci, Chem Technol, Pearl River, NY 10965 USAWyeth Ayerst Res, Chem & Screening Sci, Chem Technol, Pearl River, NY 10965 USA
机构:
Chinese Univ Hong Kong, Dept Pharmacol, Shatin, Hong Kong, Peoples R ChinaChinese Univ Hong Kong, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
Zhou, Xin
Leung, Pak Ho Henry
论文数: 0引用数: 0
h-index: 0
机构:
Nanyang Polytech, Sch Chem & Life Sci, Singapore, SingaporeChinese Univ Hong Kong, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
Leung, Pak Ho Henry
Ting, Soh Jing
论文数: 0引用数: 0
h-index: 0
机构:
Nanyang Polytech, Sch Chem & Life Sci, Singapore, SingaporeChinese Univ Hong Kong, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
Ting, Soh Jing
Ye, Yang
论文数: 0引用数: 0
h-index: 0
机构:
Shanghai Inst Mat Med, Dept Nat Prod Chem, Shanghai, Peoples R ChinaChinese Univ Hong Kong, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
Ye, Yang
Zhang, Li
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R ChinaChinese Univ Hong Kong, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
Zhang, Li
Zuo, Zhong
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R ChinaChinese Univ Hong Kong, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
Zuo, Zhong
Lin, Ge
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Univ Hong Kong, Dept Pharmacol, Shatin, Hong Kong, Peoples R ChinaChinese Univ Hong Kong, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
机构:Chinese Univ Hong Kong, Fac Med, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
Leung, PHH
Zhang, L
论文数: 0引用数: 0
h-index: 0
机构:Chinese Univ Hong Kong, Fac Med, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
Zhang, L
Zuo, Z
论文数: 0引用数: 0
h-index: 0
机构:Chinese Univ Hong Kong, Fac Med, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
Zuo, Z
Lin, G
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Univ Hong Kong, Fac Med, Dept Pharmacol, Shatin, Hong Kong, Peoples R ChinaChinese Univ Hong Kong, Fac Med, Dept Pharmacol, Shatin, Hong Kong, Peoples R China
机构:
China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China
Hu Lin
Tong Huan
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China
Tong Huan
Ding Ru
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China
Ding Ru
Wang Zhanbo
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Ctr New Drug Safety & Evaluat & Res, Nanjing 211198, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China
Wang Zhanbo
You Linjun
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Ctr New Drug Safety & Evaluat & Res, Nanjing 211198, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China
You Linjun
Yang Jin
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China